See how top analysts and institutions rate MDT — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Wolfe Research | Upgrade | Underperform → Peer Perform | 2025-06-30 | |
| Leerink Partners | Initiated | Outperform | $110 | 2025-06-16 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 4 | 12 | 15 | 1 | 0 |
| October 2025 | 4 | 12 | 15 | 1 | 0 |
| September 2025 | 4 | 12 | 15 | 1 | 0 |
| July 2025 | 4 | 13 | 14 | 0 | 1 |
The majority of institutional investors have issued a "Buy" rating for MDT, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
